|
Martinez-Balsalobre E, Guervilly JH, van Asbeck-van der Wijst J, Perez-Oliva AB, Lachaud C. Beyond current treatment of Fanconi Anemia: What do advances in cell and gene-based approaches offer? Blood Rev. 2023 Jul;60:101094. doi: 10.1016/j.blre.2023.101094. Epub 2023 Apr 28. PubMed PMID: 37142543.
AÑO: 2023; IF: 6.9
|
37142543
|
Rodriguez-Ruiz L, Lozano-Gil JM, Naranjo-Sanchez E, Martinez-Balsalobre E, Martinez-Lopez A, Lachaud C, Blanquer M, Phung TK, Garcia-Moreno D, Cayuela ML, Tyrkalska SD, Perez-Oliva AB, Mulero V. ZAKalpha/P38 kinase signaling pathway regulates hematopoiesis by activating the NLRP1 inflammasome. EMBO Mol Med. 2023 Oct 11;15(10):e18142. doi: 10.15252/emmm.202318142. Epub 2023 Sep 7. PubMed PMID: 37675820; PubMed Central PMCID: PMC10565642.
AÑO: 2023; IF: 9.0
|
|
Luciano AM, Di Martile M, Perez-Oliva AB, Di Caprio M, Foddai ML, Buglioni S, Mulero V, Del Bufalo D. Exploring association of melanoma-specific Bcl-xL with tumor immune microenvironment. J Exp Clin Cancer Res. 2023 Jul 24;42(1):178. doi: 10.1186/s13046-023-02735-9. PubMed PMID: 37488586; PubMed Central PMCID: PMC10364435.
AÑO: 2023; IF: 11.4
|
|
Sanchez-Villalobos M, Campos Banos E, Juan Fita MJ, Egea Mellado JM, Gonzalez Gallego I, Beltran Videla A, Berenguer Piqueras M, Bermudez Cortes M, Moraleda Jimenez JM, Guillen Navarro E, Salido Fierrez E, Perez-Oliva AB. A Newborn Screening Program for Sickle Cell Disease in Murcia (Spain). Int J Neonatal Screen. 2023 Oct 10;9(4):55. doi: 10.3390/ijns9040055. PubMed PMID: 37873846; PubMed Central PMCID: PMC10594431.
AÑO: 2023; IF: 3.5
|
|
Sanchez Villalobos M, Salido Fierrez E, Martinez Nieto J, Garcia Garay MC, Beltran Videla A, Perez Oliva AB, Blanquer Blanquer M, Moraleda Jimenez JM. Case Report: alpha-Spectrin Mutation Associated with alphaLELY Polymorphism Responsible for Hereditary Pyropoikilocytosis. Hematol Rep. 2022 Oct 8;14(4):300-304. doi: 10.3390/hematolrep14040043. PubMed PMID: 36278520; PubMed Central PMCID: PMC9589974.
AÑO: 2022
|